![Bradley Hodges](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Hodges
Private Equity Investor chez
CureDuchenne Ventures LLC
Profil
Bradley Hodges has founded Prothelia, Inc. in 2007, where he holds the title of Chief Scientific Officer.
Currently, he is a Partner at CureDuchenne Ventures LLC since 2022.
Postes actifs de Bradley Hodges
| Sociétés | Poste | Début |
|---|---|---|
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Private Equity Investor | 01/05/2022 |
Anciens postes connus de Bradley Hodges
| Sociétés | Poste | Fin |
|---|---|---|
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
